Cardiology Fiesta 2016
B

Is Coumadin Dead? Are Novel Anticoagulant Drugs the Optimal Therapy? How to Choose?

By Cardiology Fiesta 2016 FEATURING Bethany Kalich
By Cardiology Fiesta 2016 FEATURING Bethany Kalich
420 views
December 9, 2016
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
14:39
Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice
15:40
ACC 2022 Conference Coverage

ACC 2022: Triple Therapy - When to Use and How Long

Feat. D. Kumbhani
57:30
McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani
21:51
Cedars Sinai

Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…

Feat. W. Boden
19:47
Complex Coronary Cases

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…

Feat. U. Baber
34:40
Icahn School of Medicine at Mount Sinai

Peri-Operative Management of Anticoagulation

Feat. A. Dunn
15:41
UCLA Health

Anticoagulation in ECLS - To Bleed, or Not to Clot...

Feat. A. Young
20:50
Salim Virani

Aspirin for Primary Prevention

33:50
Houston Methodist DeBakey Heart and Vascular Center

Left Ventricular Thrombosis: An Overview

Feat. Y. Saleh
20:06
Canadian Collaborative Research Network

Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?

Feat. M. Sabatine
12:46
AHA 2022 Conference Coverage

AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…

Feat. F. Bakaeen
15:13
Cardiometabolic Health Congress (CMHC)

Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…

Feat. D. Bhatt
11:50
TCT 2023 Insights

TCT 2023 Insights: Where Do Antithrombotics Fit In?

Feat. M. Bonaca
16:34
AHA 2022 Conference Coverage

AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Hepa…

Feat. G. W. Stone
12:53
Scottsdale Interventional Forum 2018

What is the Optimal DAPT Duration?

Feat. R. Yeh
45:37
Cedars Sinai

Eliquis: Alternative Anticoagulation for HeartMate 3 Ventricular Ass…

Feat. M. Slaughter
14:31
ARCH Advanced Revascularization Symposium

Updates on Pharmacology in the Cath Lab

Feat. J. Goetz
15:14
Cardiometabolic Health Congress (CMHC)

PAD in Patients with (a Risk of) Cardiometabolic Disease: What Is th…

Feat. D. Bhatt
16:55
Scottsdale Interventional Forum 2015

PCI Pharmacology in 2015: Choosing the Right Antiplatelet & Anti…

Feat. S. Bailey
19:42
Northwell Health Cardiovascular Fellows Course 2022

PCI Pharmacology

Feat. V. Singh